Factors Associated with Mortality Among Severe Omicron Patients for COVID-19

References

• World Health Organization. Classification of omicron (B.1.1.529): SARS-CoV-2 variant of concern; 2021. Available from: https://www.who.int/news/item/26-11-2021classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern. Accessed March 9, 2022.
   Google Scholar
• Centers for Disease Control and Prevention. Science brief: omicron (B.1.1.529) variant. Available from: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-omicron-variant.html. Accessed March 9, 2022.
   Google Scholar
• Chinese center for disease control and prevention; 2023. Available from: https://www.chinacdc.cn/jkzt/crb/zl/szkb_11803/jszl_13141/202307/t20230705_267605.html. Accessed March 18, 2024.
   Google Scholar
• GISAID. Tracking of variants. Available from: https://www.gisaid.org/hcov19variants/. Accessed October 22, 2023.
   Google Scholar
• Wolter N, Jassat W, Walaza S, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022;399(10323):437–446. doi:10.1016/S0140-6736(22)00017-4
   PubMed Web of Science ®Google Scholar
• Ferguson N, Ghani A, Hinsley W, Volz E Report 50: hospitalisation risk for omicron cases in England; 2021. Available from: https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-50severity-omicron/. Accessed March 9, 2022.
   Google Scholar
• Ulloa AC, Buchan SA, Daneman N, Brown KA. Estimates of SARS-CoV-2 omicron variant severity in Ontario, Canada. JAMA. 2022;327(13):1286–1288. doi:10.1001/jama.2022.2274
   PubMed Web of Science ®Google Scholar
• Lewnard JA, Hong VX, Patel MM, Kahn R, Lipsitch M, Tartof SY. Clinical outcomes among patients infected with omicron (B.1.1.529) SARS-CoV-2 variant in southern California. Nat Med. 2022;28(9):1933–1943. doi:10.1038/s41591-022-01887-z
   PubMed Web of Science ®Google Scholar
• Abdullah F, Myers J, Basu D, et al. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in Tshwane, South Africa. Int J Infect Dis. 2022;116:38–42. doi:10.1016/j.ijid.2021.12.357
   PubMed Web of Science ®Google Scholar
• Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):775–787. doi:10.1001/jama.2016.0289
   PubMed Web of Science ®Google Scholar
• Andrews N, Stowe J, Kiresbom F, et al. Effectiveness of COVID-19 vaccines against the omicron (B.1.1.529) variant of concern. NEJM. 2022;399:1303–1312.
   Google Scholar
• Mertoglu C, Huyut MT, Olmez H, et al. COVID-19 is more dangerous for older people and its severity is increasing: a case-control study. Med Gas Res. 2022;12(2):51–54. doi:10.4103/2045-9912.325992
   PubMed Web of Science ®Google Scholar
• Kosidlo JW, Wolszczak-Biedrzycka B, Dymicka-Piekarska V, et al. Clinical significance and diagnostic utility of NLR, LMR, PLR and SII in the Course of COVID-19: a literature review. J Inflamm Res. 2023;16:539–562. doi:10.2147/JIR.S395331
   PubMed Web of Science ®Google Scholar
• Proctor MJ, McMillan DC, Morrison DS, et al. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer. 2012;107(4):695–699. doi:10.1038/bjc.2012.292
   PubMed Web of Science ®Google Scholar
• Yang T, Hao L, Yang X, et al. Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis. BMJ open. 2021;11(9):e049123. doi:10.1136/bmjopen-2021-049123
   PubMed Web of Science ®Google Scholar
• Citu C, Gorun F, Motoc A, et al. The Predictive Role of NLR, d-NLR, MLR, and SIRI in COVID-19 Mortality. Diagnostics. 2022;12(1):122. doi:10.3390/diagnostics12010122
   Web of Science ®Google Scholar
• Information on COVID-19 Treatment, Prevention and Research. COVID-19 Treatment Guidelines; 2023, Available from: https://www.covid19treatmentguidelines.nih.gov/. Accessed March 18, 2024.
   Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–184. doi:10.1159/000339789
   PubMedGoogle Scholar
• Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–2533. doi:10.1001/jama.2012.5669
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Hh Z, Xj H, Huang X-J. Abnormal indexes of liver and kidney injury markers predict severity in COVID-19 patients. Infec Drug Resist. 2021;14:3029–3040. doi:10.2147/IDR.S321915
   PubMed Web of Science ®Google Scholar
• Gong J, Ou J, Qiu X, et al. A tool for early prediction of severe coronavirus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China. Clin Infect Dis. 2020;71(15):833–840. doi:10.1093/cid/ciaa443
   PubMed Web of Science ®Google Scholar
• Grenader T, Nash S, Adams R, et al. Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study. Br J Cancer. 2016;114(6):612–615. doi:10.1038/bjc.2016.23
   PubMed Web of Science ®Google Scholar
• Dymicka-Piekarska V, Dorf J, Milewska A, et al. Neutrophil/Lymphocyte Ratio (NLR) and Lymphocyte/Monocyte Ratio (LMR) – risk of Death Inflammatory Biomarkers in Patients with COVID-19. J Inflamm Res. 2023;16(16):2209–2222. doi:10.2147/JIR.S409871
   PubMedGoogle Scholar
• Fois AG, Paliogiannis P, Scano V, et al. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules. 2020;25(23):5725. doi:10.3390/molecules25235725
   PubMed Web of Science ®Google Scholar
• Sun S, Cai X, Wang H, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta. 2020;507:174–180. doi:10.1016/j.cca.2020.04.024
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Barnes BJ, Adrover JM, Baxter-Stoltzfus A, et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med. 2020;217(6):doi:10.1084/jem.20200652
   PubMed Web of Science ®Google Scholar
• Kusumanto YH, Dam WA, Hospers GAP, et al. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular-endothelial growth factor. Angiogenesis. 2003;6(4):283–287. doi:10.1023/B:AGEN.0000029415.62384.ba
   PubMedGoogle Scholar
• Hanrahan V, Currie MJ, Gunningham SP, et al. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol. 2003;200(2):183–194. doi:10.1002/path.1339
   PubMed Web of Science ®Google Scholar
• Kim SL, Lee ST, Trang KTT, et al. Parthenolide exerts inhibitory effects on angiogenesis through the downregulation of VEGF/VEGFRs in colorectal cancer. Int J Mol Med. 2014;33(5):1261–1267. doi:10.3892/ijmm.2014.1669
   PubMed Web of Science ®Google Scholar
• Kuper H, Adami H-O, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med. 2000;248(3):171–183. doi:10.1046/j.1365-2796.2000.00742.x
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 1995;55(3):562–565.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhou L, Kou Y, Kou J. Activated neutrophils in the initiation and progression of COVID-19: hyperinflammation and immunothrombosis in COVID-19. Am J Transl Res. 2022;14(3):1454–1468.
   PubMed Web of Science ®Google Scholar
• Rabinowich H, Cohen R, Bruderman I, Steiner Z, Klajman A. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res. 1987;47(1):173–177.
   PubMed Web of Science ®Google Scholar
• Menges T, Engel J, Welters I, et al. Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications. Crit Care Med. 1999;27(4):733–740. doi:10.1097/00003246-199904000-00026
   PubMed Web of Science ®Google Scholar
• Choi KW, Chau TN, Tsang O, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139(9):715–723. doi:10.7326/0003-4819-139-9-200311040-00005
   PubMed Web of Science ®Google Scholar
• Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014;29:301–306. doi:10.1016/j.ijid.2014.09.003
   PubMed Web of Science ®Google Scholar
• Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847. doi:10.1111/jth.14768
   PubMed Web of Science ®Google Scholar
• Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448–457. doi:10.1038/ni.3153
   PubMed Web of Science ®Google Scholar
• Ramasamy S, Subbian S. Critical determinants of cytokine storm and type i interferon response in COVID-19 pathogenesis. Clin Microbiol Rev. 2021;34(3):e00299–20. doi:10.1128/CMR.00299-20
   PubMed Web of Science ®Google Scholar
• Wolszczak-Biedrzycka B, Dorf J, Milewska A, et al. The Diagnostic Value of Inflammatory Markers (CRP, IL6, CRP/IL6, CRP/L, LCR) for Assessing the Severity of COVID-19 Symptoms Based on the MEWS and Predicting the Risk of Mortality. J Inflamm Res. 2023;(16):2173–2188. doi:10.2147/JIR.S406658
   PubMedGoogle Scholar
• Kishimoto T, Kang S IL-6 revisited: from rheumatoid arthritis to CAR T Cell Therapy and COVID-19. Annu Rev Immunol. 2022;40:323–348. doi:10.1146/annurev-immunol-101220-023458
   PubMed Web of Science ®Google Scholar
• Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020;117(20):10970–10975. doi:10.1073/pnas.2005615117
   PubMed Web of Science ®Google Scholar
• Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19. J Infect. 2020;80(6):607–613. doi:10.1016/j.jinf.2020.03.037
   PubMed Web of Science ®Google Scholar
• Chen L, Yu J, He W, et al. Risk factors for death in 1859 subjects with COVID-19. Leukemia. 2020;34(8):2173–2183. doi:10.1038/s41375-020-0911-0
   PubMed Web of Science ®Google Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–1581. doi:10.1001/jama.2020.5394
   PubMed Web of Science ®Google Scholar